Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston
boston blog main
2
×
boston top stories
life sciences
national blog main
national top stories
akcea therapeutics
alnylam pharmaceuticals
avapritinib
biotech
blueprint medicines
cancer
cancer drugs
capmatinib
drugs
eli lilly
europe blog main
europe top stories
european medicines agency
fda
gastrointestinal stromal tumors
genentech
harvard pilgrim health care
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
institute for clinical and economic review
life science
medullary thyroid cancer
new york blog main
new york top stories
non-small cell lung cancer
novartis
onpattro
patisiran
pfizer
pralsetinib
roche
san diego blog main
What
approves
2
×
drug
fda
address
alnylam
approval
blueprint
cancer
carries
cells
certain
designed
ema
employ
europe
follows
gene
genetic
harmful
hits
interference
latest
make
medicine
medicines
method
mute
pass
protein
ret
rna
rnai
signature
signatures
targeted
targeting
therapy
uses
way
Language
unset
Current search:
approves
×
photo
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
